Eligible ages
Ages 2-17
Compensation
Available for time and travel
Who is eligible
Children between 2 and 17 years of age who: - Have ongoing trouble falling asleep - Have a parent or legal guardian able to provide consent and accompany the child to study visits - Who are willing and able to comply with study requirements There may be additional requirements that our team will discuss with you to see if your child qualifies.
What's involved
The study includes a screening period, a 3-month treatment period, and a 9-month open-label extension during which all participants receive the active study medication. Qualified participants may: • Receive compensation for time and travel • See a study doctor at no cost • Receive access to a new investigational treatment • Have many study visits conducted remotely (by phone or in-home nurse) when appropriate Participation is voluntary, and health insurance is not required.
Where this study is run
ALSA Research – Manhattan
425 5th Avenue, 6th Floor, Unit 602, New York, NY 10016